30
Participants
Start Date
March 31, 2024
Primary Completion Date
September 30, 2025
Study Completion Date
December 31, 2025
THC
Participants will be randomly assigned to the study treatment. THC dose will be gradually increased until 25 mg. Treatment will be taken orally at bedtime for 15 weeks.
CBD
Participants will be randomly assigned to the study treatment. CBD dose will be gradually increased until 50 mg. Treatment will be taken orally at bedtime for 15 weeks.
Multiple Sclerosis Society of Canada
OTHER
University of Calgary
OTHER